TSHA Taysha Gene Therapies, Inc. - Common Stock
NASDAQ · Biotechnology · Visualizza su SEC EDGAR ↗ chiudi Ott 2, 2026 10-K/10-Q Ago 11, 2026
$4,63
· % dell'intervallo 52 sett.
· sopra il minimo
· al massimo
$3,69minimo 52 sett.
$7,30massimo 52 sett.
Capitalizzazione di Mercato (MRQ)
$1.51B
P/E (TTM)
-11.0
EPS (TTM)
$-0.42
Ricavi (TTM)
$5M
i tuoi badge
Intervallo 52 sett.
$4–$7
Rating Analisti
BUY
Prezzo Obiettivo
$13
P/E
-11.0
ROE
-47.1%
Margine di Profitto Netto
-2728.0%
La tua barra dei badge è vuota — aggiungi una metrica a piacere in questa pagina.
TSHA Snapshot del titolo Prezzo, capitalizzazione di mercato, P/E, EPS, ROE, debito/capitale proprio, intervallo 52 settimane
Prezzo
$4.63
Capitalizzazione di Mercato (MRQ)
$1.51B
P/E (TTM)
-11.0
EPS (TTM)
$-0.42
Ricavi (TTM)
$5M
ROE (TTM)
-47.1%
D/E Debito/Patrimonio (MRQ)
0.1
Intervallo 52 sett.
$4–$7
TSHA Grafico del prezzo delle azioni OHLCV giornaliero con indicatori tecnici — panoramica, zoom e personalizza la tua visualizzazione
intervallo
barre
La granularità delle barre si adatta al periodo selezionato — passa il mouse sul grafico per vedere apertura/massimo/minimo/chiusura di una barra.
Performance decennale Andamento di ricavi, utile netto, margini e EPS
Ricavi$10M2022-12-31 → 2025-12-31
EPS$-0.342021-12-31 → 2025-12-31
Flusso di cassa libero$-94M2020-12-31 → 2025-12-31
Margine netto-2728.0%2023-12-31 → 2025-12-31
Valutazione e Rapporti
Valutazione Rapporti P/E, P/S, P/B, EV/EBITDA — il titolo è costoso o economico?
| Metrica | Tendenza 5 anni | TSHA | media 5 anni | Mediana dei peer | Verdetto |
|---|---|---|---|---|---|
| P/E (TTM) | -11.0media 5 anni ≈-5.2 | ≈-5.2 | · | · | |
| P/S (TTM) | 274.6media 5 anni ≈74.8 | ≈74.8 | 37.8 | Sopravvalutato | |
| P/B (MRQ) | 3.9media 5 anni ≈5.1 | ≈5.1 | 3.3 | Sopravvalutato | |
| EV / EBITDA | -9.6media 5 anni ≈-4.9 | ≈-4.9 | · | · | |
| Prezzo / FCF (TTM) | -11.4media 5 anni ≈-7.2 | ≈-7.2 | · | · | |
| Prezzo / Flusso di cassa (TTM) | -11.4media 5 anni ≈-7.4 | ≈-7.4 | · | · | |
| EV / Revenue (EV / Ricavi) | 108.5media 5 anni ≈59.6 | ≈59.6 | · | · | |
| EV / FCF | -11.3media 5 anni ≈-5.6 | ≈-5.6 | · | · | |
| Price / Tangible Book (Prezzo / Valore contabile tangibile) | 5.4media 5 anni ≈34.2 | ≈34.2 | · | · |
La mediana dei peer viene calcolata su base standardizzata per metrica e potrebbe non corrispondere sempre alla base TTM/MRQ mostrata per questo titolo.
Redditività Margini lordi, operativi e netti; ROE, ROA, ROIC
| Metrica | Tendenza 5 anni | TSHA | media 5 anni | Mediana dei peer | Verdetto |
|---|---|---|---|---|---|
| Margine Operativo (TTM) | -2792.3%media 5 anni ≈-899.0% | ≈-899.0% | -890.5% | Debole | |
| EBITDA Margin (Margine EBITDA) | -1130.7%media 5 anni ≈-899.0% | ≈-899.0% | -890.5% | Debole | |
| Margine di Profitto Netto (TTM) | -2728.0%media 5 anni ≈-969.7% | ≈-969.7% | -874.4% | Debole | |
| ROA (TTM) | -37.2%media 5 anni ≈-61.3% | ≈-61.3% | -41.9% | In linea | |
| ROE (TTM) | -47.1%media 5 anni ≈-291.9% | ≈-291.9% | -55.3% | Di prim'ordine |
Salute finanziaria Debito, liquidità, solvibilità — solidità del bilancio
| Metrica | Tendenza 5 anni | TSHA | media 5 anni | Mediana dei peer | Verdetto |
|---|---|---|---|---|---|
| Debito / Patrimonio Netto (MRQ) | 0.1media 5 anni ≈0.4 | ≈0.4 | 0.1 | In linea | |
| Rapporto corrente (MRQ) | 17.8media 5 anni ≈6.2 | ≈6.2 | 6.5 | Liquidità elevata | |
| Quick Ratio | 12.0media 5 anni ≈6.0 | ≈6.0 | 5.5 | Liquidità elevata | |
| Debito a lungo termine / Patrimonio netto (MRQ) | 0.1media 5 anni ≈0.4 | ≈0.4 | · | · |
Crescita Crescita di ricavi, EPS e utile netto: YoY, CAGR 3Y, CAGR 5Y
| Metrica | Tendenza 5 anni | TSHA | media 5 anni | Mediana dei peer | Verdetto |
|---|---|---|---|---|---|
| Revenue YoY (Ricavi YoY) | 17.3%media 5 anni ≈162.9% | ≈162.9% | · | · | |
| Revenue CAGR 3Y (CAGR Ricavi 3Y) | 57.5% | · | · | · |
Efficienza del Capitale Rotazione delle attività, rotazione delle scorte, rotazione dei crediti
| Metrica | Tendenza 5 anni | TSHA | media 5 anni | Mediana dei peer | Verdetto |
|---|---|---|---|---|---|
| Asset Turnover (Rotazione delle attività) | 0.0media 5 anni ≈0.1 | ≈0.1 | 0.1 | Debole | |
| Revenue / Employee (Ricavi / Dipendente) | ≈$98.7K | · | · | · |
valore · ≈ media 5 anni · mediana del settore · giudizio rispetto alla mediana
Cronologia utili EPS effettivo vs stima, surprise %, tasso di superamento, data prossimi utili
Sorpresa media
0.53%
Prossimo report
Nov 02, 2026
| Periodo | Rapporto | EPS Actual | EPS Stimato | Sorpresa |
|---|---|---|---|---|
| 30 Giugno 2026 | Ago 17, 2026 | $-0.14 | $-0.12 | -17.7% |
| 31 Marzo 2026 | Mag 20, 2026 | $-0.12 | $-0.10 | -20.5% |
| 31 Dicembre 2025 | $-0.08 | $-0.10 | 18.5% | |
| 30 Settembre 2025 | $-0.09 | $-0.09 | 0.00% | |
| 30 Giugno 2025 | $-0.09 | $-0.08 | -9.1% | |
| 31 Marzo 2025 | $-0.08 | $-0.09 | 15.3% | |
| 31 Dicembre 2024 | $-0.07 | $-0.08 | 17.4% |
Fondamentali Completi Tutte le metriche per anno — conto economico, stato patrimoniale, rendiconto finanziario
Conto Economico
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | $10M | $8M | $15M | $3M | |
| R&D Expense | $86M | $66M | $57M | $91M | |
| SG&A Expense | $34M | $29M | $30M | $37M | |
| Operating Expenses | $120M | $100M | $88M | $165M | |
| Operating Income | $-110M | $-91M | $-72M | $-162M | |
| Interest Expense | · | · | $5M | $4M | |
| Interest Income | $9M | $7M | $4M | · | |
| Other Non-op | $-291.0K | $-110.0K | $-47.0K | $-18.0K | |
| Income Tax | $0 | $0 | $0 | $0 | |
| Net Income | $-109M | $-89M | $-112M | $-166M | |
| EPS (Basic) | $-0.34 | $-0.36 | $-0.96 | $-3.78 | |
| EPS (Diluted) | $-0.34 | $-0.36 | $-0.96 | $-3.78 | |
| Shares (Basic) | 319,711,972 | 250,134,421 | 116,121,482 | 43,952,015 | |
| Shares (Diluted) | 319,711,972 | 250,134,421 | 116,121,482 | 43,952,015 | |
| EBITDA | $-110M | $-91M | $-72M | · |
Stato Patrimoniale
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Cash & Equivalents | $320M | $139M | $144M | $88M | |
| Prepaid Expense | $4M | $3M | $3M | $9M | |
| Other Current Assets | $802.0K | $308.0K | $292.0K | $466.0K | |
| Current Assets | $325M | $142M | $150M | $96M | |
| PP&E (Net) | $7M | $7M | $11M | $15M | |
| PP&E (Gross) | $11M | $11M | $14M | $17M | |
| Accum. Depreciation | $5M | $4M | $3M | $2M | |
| Other Non-current Assets | $183.0K | $217.0K | $304.0K | $1M | |
| Total Assets | $343M | $160M | $173M | $126M | |
| Accounts Payable | $6M | $4M | $6M | $11M | |
| Current Liabilities | $27M | $26M | $37M | $63M | |
| Capital Leases | $18M | $17M | $19M | $20M | |
| Other Non-current Liabilities | $2M | $1M | $2M | $4M | |
| Total Liabilities | $96M | $89M | $98M | $125M | |
| Long-term Debt | · | · | · | $38M | |
| Total Debt | $50M | $44M | $41M | · | |
| Common Stock | $3.0K | $2.0K | $2.0K | $1.0K | |
| Paid-in Capital | $958M | $678M | $588M | $402M | |
| Retained Earnings | $-711M | $-602M | $-513M | $-401M | |
| AOCI | $-192.0K | $-4M | · | · | |
| Stockholders' Equity | $247M | $72M | $75M | $949.0K | |
| Liabilities + Equity | $343M | $160M | $173M | $126M | |
| Shares Outstanding | 285,051,648 | 204,943,306 | 186,960,193 | 63,207,507 |
Flusso di cassa
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Stock-based Comp | $13M | $13M | $8M | $18M | |
| Operating Cash Flow | $-93M | $-81M | $-73M | $-88M | |
| CapEx | $738.0K | $374.0K | $4M | $21M | |
| Investing Cash Flow | $-604.0K | $-363.0K | $-7M | $-25M | |
| Stock Issued | · | · | $500.0K | · | |
| Financing Cash Flow | $275M | $77M | $136M | $52M | |
| Net Change in Cash | $181M | $-5M | $56M | $-61M | |
| Free Cash Flow | $-94M | $-82M | $-77M | · |
Redditività
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Operating Margin | -1130.7% | -1097.5% | -468.8% | · | |
| Net Margin | -1115.3% | -1071.6% | -722.1% | · | |
| EBITDA Margin | -1130.7% | -1097.5% | -468.8% | · | |
| ROA | -43.3% | -53.6% | -74.6% | · | |
| ROE | -44.0% | -111.4% | -864.1% | · |
Liquidità e Solvibilità
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Current Ratio | 12.2 | 5.4 | 4.1 | · | |
| Quick Ratio | 12.0 | 5.3 | 3.9 | · | |
| Debt / Equity | 0.2 | 0.6 | 0.5 | · | |
| LT Debt / Equity | 0.2 | 0.6 | 0.5 | · | |
| Interest Coverage | · | · | -14.5 | · |
Efficienza
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.1 | 0.1 | · |
Per Azione
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Book Value / Share | $0.87 | $0.35 | $0.40 | · | |
| Revenue / Share | $0.03 | $0.03 | $0.13 | · | |
| Cash Flow / Share | $-0.29 | $-0.32 | $-0.63 | · | |
| Cash / Share | $1.12 | $0.68 | $0.77 | · | |
| EPS (TTM) | $-0.34 | $-0.36 | $-0.96 | $-3.78 |
Tassi di Crescita
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue YoY | 17.3% | -46.1% | 517.6% | · | |
| Revenue CAGR 3Y | 57.5% | · | · | · |
Valutazione (TTM)
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue TTM | $10M | $8M | $15M | $3M | |
| Net Income TTM | $-109M | $-89M | $-112M | $-166M | |
| Market Cap | $1.57B | $355M | $331M | · | |
| Enterprise Value | $1.30B | $259M | $227M | · | |
| P/E | -16.2 | -4.8 | -1.8 | -0.6 | |
| P/S | 160.4 | 42.5 | 21.4 | · | |
| P/B | 6.3 | 5.0 | 4.4 | · | |
| P / Tangible Book | 6.3 | 5.0 | 4.4 | 150.5 | |
| P / Cash Flow | -16.8 | -4.4 | -4.5 | · | |
| P / FCF | -16.7 | -4.3 | -4.3 | · | |
| EV / EBITDA | -11.7 | -2.8 | -3.1 | · | |
| EV / FCF | -13.8 | -3.2 | -3.0 | · | |
| EV / Revenue | 132.8 | 31.1 | 14.7 | · | |
| Earnings Yield | -6.2% | -20.8% | -54.2% | -167.3% |
Conto Economico
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $0 | $5M | $0 | $2M | $2M | $2M | $2M | $1M | $3M | $4M | $5M | $2M | $5M | |
| R&D Expense | $39M | $34M | $25M | $26M | $20M | $16M | $15M | $15M | $15M | $21M | $13M | $12M | $20M | $13M | |
| SG&A Expense | $12M | $10M | $9M | $8M | $9M | $8M | $7M | $8M | $7M | $7M | $7M | $9M | $6M | $9M | |
| Operating Expenses | $47M | $43M | $34M | $34M | $29M | $24M | $22M | $28M | $22M | $28M | $20M | $21M | $26M | $21M | |
| Operating Income | $-47M | $-43M | $-28M | $-34M | $-27M | $-21M | $-20M | $-26M | $-21M | $-24M | $-16M | $-16M | $-23M | $-17M | |
| Interest Expense | · | · | · | · | · | · | · | · | $27.0K | $29.0K | · | $1M | $1M | $1M | |
| Interest Income | $2M | $3M | $3M | $3M | $2M | $1M | $2M | $2M | $1M | $2M | $2M | $1M | · | · | |
| Other Non-op | $-88.0K | $-31.0K | $-30.0K | $-37.0K | $-237.0K | $13.0K | $-66.0K | $-81.0K | $42.0K | $-5.0K | $-23.0K | $-19.0K | $3.0K | $-8.0K | |
| Income Tax | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | · | $0 | $0 | $0 | |
| Net Income | $-47M | $-42M | $-28M | $-33M | $-27M | $-22M | $-19M | $-26M | $-21M | $-24M | $48M | $-117M | $-25M | $-18M | |
| EPS (Basic) | $-0.13 | $-0.12 | $-0.08 | $-0.09 | $-0.09 | $-0.08 | $-0.07 | $-0.10 | $-0.09 | $-0.10 | $0.63 | $-0.93 | $-0.38 | $-0.28 | |
| EPS (Diluted) | $-0.13 | $-0.12 | $-0.08 | $-0.09 | $-0.09 | $-0.08 | $-0.07 | $-0.10 | $-0.09 | $-0.10 | $0.63 | $-0.93 | $-0.38 | $-0.28 | |
| Shares (Basic) | 369,044,040 | 366,632,827 | · | 353,309,524 | 297,988,978 | 269,306,331 | · | 267,824,045 | 232,821,553 | 231,249,344 | · | 125,700,799 | 64,244,531 | 63,260,905 | |
| Shares (Diluted) | 369,044,040 | 366,632,827 | · | 353,309,524 | 297,988,978 | 269,306,331 | · | 267,824,045 | 232,821,553 | 231,249,344 | · | 125,700,799 | 64,244,531 | 63,260,905 | |
| EBITDA | $-47M | $-43M | · | $-34M | $-27M | $-21M | · | $-26M | $-21M | $-24M | · | $-16M | $-23M | $-17M |
Stato Patrimoniale
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $455M | $277M | $320M | $297M | $313M | $117M | $139M | $158M | $173M | $124M | $144M | $164M | $45M | $63M | |
| Prepaid Expense | $6M | $5M | $4M | $2M | $3M | $4M | $3M | $3M | $3M | $4M | $3M | $6M | $9M | $9M | |
| Other Current Assets | $851.0K | $1M | $802.0K | $456.0K | $657.0K | $536.0K | $308.0K | $465.0K | $206.0K | $149.0K | $292.0K | $404.0K | $510.0K | $532.0K | |
| Current Assets | $461M | $282M | $325M | $300M | $316M | $121M | $142M | $162M | $178M | $131M | $150M | $172M | $54M | $72M | |
| PP&E (Net) | $2M | $6M | $7M | $7M | $7M | $7M | $7M | $8M | $11M | $11M | $11M | $11M | $14M | $15M | |
| PP&E (Gross) | $8M | $11M | $11M | $11M | $11M | $11M | $11M | $12M | $14M | $14M | $14M | $14M | $16M | $17M | |
| Accum. Depreciation | $5M | $5M | $5M | $4M | $4M | $4M | $4M | $4M | $4M | $3M | $3M | $3M | $2M | $2M | |
| Other Non-current Assets | $106.0K | $181.0K | $183.0K | $184.0K | $186.0K | $188.0K | $217.0K | $220.0K | $288.0K | $304.0K | $304.0K | $304.0K | $304.0K | $1M | |
| Total Assets | $470M | $300M | $343M | $317M | $333M | $138M | $160M | $180M | $200M | $153M | $173M | $196M | $82M | $102M | |
| Accounts Payable | $9M | $5M | $6M | $5M | $8M | $4M | $4M | $5M | $9M | $10M | $6M | $8M | $11M | $9M | |
| Current Liabilities | $26M | $20M | $27M | $29M | $25M | $23M | $26M | $29M | $34M | $39M | $37M | $180M | $51M | $54M | |
| Capital Leases | $6M | $18M | $18M | $17M | $17M | $17M | $17M | $18M | $18M | $18M | $19M | $19M | $20M | $20M | |
| Other Non-current Liabilities | $2M | $2M | $2M | $2M | $1M | $1M | $1M | $1M | $1M | $2M | $2M | $4M | $4M | $4M | |
| Total Liabilities | $83M | $88M | $96M | $98M | $85M | $83M | $89M | $91M | $92M | $99M | $98M | $245M | $119M | $117M | |
| Long-term Debt | · | · | · | · | · | · | · | · | · | · | · | · | $38M | $38M | |
| Total Debt | $49M | $49M | · | $51M | $41M | $42M | · | $43M | $38M | $41M | · | $39M | $38M | $38M | |
| Common Stock | $3.0K | $3.0K | $3.0K | $3.0K | $3.0K | $2.0K | $2.0K | $2.0K | $2.0K | $2.0K | $2.0K | $2.0K | $1.0K | $1.0K | |
| Paid-in Capital | $1.19B | $965M | $958M | $904M | $900M | $681M | $678M | $675M | $664M | $591M | $588M | $512M | $407M | $404M | |
| Retained Earnings | $-800M | $-754M | $-711M | $-683M | $-651M | $-624M | $-602M | $-584M | $-558M | $-537M | $-513M | $-561M | $-444M | $-419M | |
| AOCI | $769.0K | $985.0K | $-192.0K | $-1M | $-699.0K | $-2M | $-4M | $-2M | $2M | $-251.0K | · | · | · | · | |
| Stockholders' Equity | $387M | $212M | $247M | $219M | $249M | $55M | $72M | $89M | $109M | $54M | $75M | $-49M | $-37M | $-15M | |
| Liabilities + Equity | $470M | $300M | $343M | $317M | $333M | $138M | $160M | $180M | $200M | $153M | $173M | $196M | $82M | $102M | |
| Shares Outstanding | 325,302,280 | 287,276,885 | 285,051,648 | 273,915,373 | 272,730,060 | 205,054,570 | 204,943,306 | 204,943,306 | 201,381,450 | 187,018,275 | 186,960,193 | 186,960,193 | 64,432,637 | 63,473,349 |
Flusso di cassa
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $6M | $6M | $4M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $2M | $2M | $2M | $2M | |
| Operating Cash Flow | $-40M | $-41M | $-27M | $-24M | $-20M | $-22M | $-18M | $-22M | $-22M | $-20M | $-16M | $-18M | $-19M | $-20M | |
| CapEx | $-1.0K | $24.0K | $250.0K | $108.0K | $2.0K | $378.0K | $-2.0K | $35.0K | $201.0K | $140.0K | $17.0K | $0 | $-48.0K | $4M | |
| Investing Cash Flow | $1.0K | $-3M | $-247.0K | $-48.0K | $62.0K | $-371.0K | $13.0K | $-35.0K | $-201.0K | $-140.0K | $-10.0K | $-3M | $48.0K | $-4M | |
| Stock Issued | · | · | · | · | · | · | · | · | · | · | $0 | · | · | · | |
| Financing Cash Flow | $217M | $711.0K | $50M | $9M | $216M | $-52.0K | $-357.0K | $7M | $70M | $-22.0K | $-4M | $141M | $377.0K | $-370.0K | |
| Net Change in Cash | $176M | $-43M | $23M | $-15M | $196M | $-22M | $-19M | $-15M | $49M | $-20M | $-20M | $119M | $-18M | $-24M | |
| Free Cash Flow | · | $-41M | · | · | · | · | · | · | · | $-20M | · | · | · | $-24M |
Redditività
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | · | · | · | · | -1347.1% | -930.5% | · | -1448.4% | -1915.4% | -713.3% | · | -342.4% | -976.4% | -351.9% | |
| Net Margin | · | · | · | · | -1353.6% | -935.2% | · | -1427.5% | -1882.0% | -705.4% | · | -2467.1% | -1027.1% | -374.5% | |
| EBITDA Margin | · | · | · | · | -1347.1% | -930.5% | · | -1448.4% | -1915.4% | -713.3% | · | -342.4% | -976.4% | -351.9% | |
| ROA | -11.6% | -19.3% | · | -13.2% | -10.1% | -14.8% | · | -13.6% | -14.8% | -18.9% | · | -76.2% | -22.0% | -13.2% | |
| ROE | -14.7% | -31.8% | · | -21.3% | -15.0% | -39.5% | · | -128.6% | -58.3% | -123.7% | · | 616.4% | 1117.1% | -98.5% |
Liquidità e Solvibilità
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 17.8 | 14.0 | · | 10.5 | 12.5 | 5.4 | · | 5.5 | 5.2 | 3.4 | · | 1.0 | 1.1 | 1.3 | |
| Quick Ratio | 17.5 | 13.8 | · | 10.4 | 12.3 | 5.2 | · | 5.4 | 5.1 | 3.2 | · | 0.9 | 0.9 | 1.2 | |
| Debt / Equity | 0.1 | 0.2 | · | 0.2 | 0.2 | 0.8 | · | 0.5 | 0.3 | 0.8 | · | -0.8 | -1.0 | -2.6 | |
| LT Debt / Equity | 0.1 | 0.2 | · | 0.2 | 0.2 | 0.8 | · | 0.5 | 0.3 | 0.8 | · | -0.8 | -1.0 | -2.6 | |
| Interest Coverage | · | · | · | · | · | · | · | · | -788.9 | -839.0 | · | -11.0 | -16.2 | -12.1 |
Efficienza
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 |
Per Azione
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $1.19 | $0.74 | · | $0.80 | $0.91 | $0.27 | · | $0.43 | $0.54 | $0.29 | · | $-0.26 | $-0.58 | $-0.24 | |
| Revenue / Share | $0.00 | $0.00 | · | $0.00 | $0.01 | $0.01 | · | $0.01 | $0.00 | $0.01 | · | $0.04 | $0.04 | $0.07 | |
| Cash Flow / Share | · | $-0.11 | · | · | · | $-0.08 | · | · | · | $-0.09 | · | · | · | $-0.32 | |
| Cash / Share | $1.40 | $0.96 | · | $1.09 | $1.15 | $0.57 | · | $0.77 | $0.86 | $0.66 | · | $0.88 | $0.70 | $1.00 | |
| EPS (TTM) | $-0.42 | $-0.38 | · | $-0.33 | $-0.34 | $-0.34 | · | $0.34 | $-0.49 | $-0.78 | · | $-2.55 | $-2.27 | $-2.74 |
Valutazione (TTM)
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $5M | $7M | · | $6M | $8M | $7M | · | $10M | $13M | $14M | · | · | · | · | |
| Net Income TTM | $-150M | $-130M | · | $-100M | $-93M | $-87M | · | $-23M | $-114M | $-118M | · | $-214M | $-124M | $-133M | |
| Market Cap | $2.22B | $1.28B | · | $896M | $630M | $285M | · | $412M | $451M | $537M | · | $591M | $43M | $51M | |
| Enterprise Value | $1.81B | $1.06B | · | $649M | $358M | $211M | · | $297M | $316M | $453M | · | $465M | $36M | $25M | |
| P/E | -16.2 | -11.8 | · | -9.9 | -6.8 | -4.1 | · | 5.9 | -4.6 | -3.7 | · | -1.2 | -0.3 | -0.3 | |
| P/S | 403.9 | 171.9 | · | 141.9 | 77.8 | 39.5 | · | 41.5 | 35.0 | 37.9 | · | · | · | · | |
| P/B | 5.7 | 6.1 | · | 4.1 | 2.5 | 5.2 | · | 4.6 | 4.1 | 10.0 | · | -12.0 | -1.1 | -3.4 | |
| P / Tangible Book | 5.7 | 6.1 | · | 4.1 | 2.5 | 5.2 | · | 4.6 | 4.1 | 10.0 | · | · | · | · | |
| P / Cash Flow | · | -31.4 | · | · | · | -12.9 | · | · | · | -27.1 | · | · | · | -2.5 | |
| EV / Revenue | 329.8 | 141.4 | · | 102.9 | 44.2 | 29.2 | · | 30.0 | 24.6 | 32.0 | · | · | · | · | |
| Earnings Yield | -6.2% | -8.5% | · | -10.1% | -14.7% | -24.5% | · | 16.9% | -21.9% | -27.2% | · | -80.7% | -343.4% | -343.4% |
Periodo più recente a sinistra · valori nulli mostrati come ·
Bilanci Conto economico, stato patrimoniale, flusso di cassa — annuale, ultimi 5 anni
| Metrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Ricavi | $10M | $8M | $15M | $3M | · |
| Margine Operativo % | -1130.7% | -1097.5% | -468.8% | · | · |
| Utile netto | $-109M | $-89M | $-112M | $-166M | $-175M |
| EPS Diluito | $-0.34 | $-0.36 | $-0.96 | $-3.78 | $-4.64 |
| Metrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Debito / Patrimonio Netto | 0.2 | 0.6 | 0.5 | · | 0.4 |
| Rapporto corrente | 12.2 | 5.4 | 4.1 | · | 3.1 |
| Quick Ratio | 12.0 | 5.3 | 3.9 | · | 2.9 |
| Metrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Flusso di cassa libero | $-94M | $-82M | $-77M | · | $-132M |
Proprietari istituzionali (13F) 221 filer · $2.1B totale · Aggiornato al 30 Giugno 2026
Istituzioni che segnalano il possesso di questo titolo nel loro Modulo SEC 13F trimestrale. Solo posizioni lunghe; un singolo depositante può apparire due volte per diverse gambe di opzioni. Grandi posizioni put/call contrapposte riflettono tipicamente market-making o inventario coperto, non convinzione direzionale.
Detentori
221
Valore detenuto
$2.1B
Nuove posizioni
40
Posizioni chiuse
23
Attività istituzionale — Q2 2026 vs trimestre precedente
| Nuove posizioni | Posizioni chiuse | Aumentato | Diminuito | Variazione netta delle azioni |
|---|---|---|---|---|
| 40 (+5 vs trimestre precedente) | 23 (-7 vs trimestre precedente) | 101 (+29 vs trimestre precedente) | 41 (-10 vs trimestre precedente) | +34.4M |
Confrontato con Q1 2026. Le dichiarazioni SEC Form 13F sono dovute entro 45 giorni dalla fine del trimestre più un breve margine per i dichiaranti in ritardo — i trimestri ancora all'interno di questa finestra vengono saltati a favore della coppia più recente completamente riportata.
| Istituzione | Valore | Azioni | % di 13F tracciati | Tipo |
|---|---|---|---|---|
| Avoro Capital Advisors LLC | $162.683.327 | 23.888.888 | 7,59% | Azioni |
| RA CAPITAL MANAGEMENT, L.P. | $160.413.963 | 23.555.648 | 7,48% | Azioni |
| GOLDMAN SACHS GROUP INC | $154.676.334 | 22.713.118 | 7,21% | Azioni |
| BlackRock, Inc. | $140.912.023 | 20.691.927 | 6,57% | Azioni |
| Vestal Point Capital, LP | $132.216.150 | 19.415.000 | 6,17% | Azioni |
| MORGAN STANLEY | $112.279.731 | 16.487.479 | 5,24% | Azioni |
| RTW INVESTMENTS, LP | $92.345.357 | 13.560.258 | 4,31% | Azioni |
| FMR LLC | $90.820.969 | 13.336.413 | 4,24% | Azioni |
| VANGUARD CAPITAL MANAGEMENT LLC | $84.979.232 | 12.478.595 | 3,96% | Azioni |
| STATE STREET CORP | $77.783.275 | 11.421.920 | 3,63% | Azioni |
| VANGUARD GROUP INC | $72.972.929 | 13.267.805 | 3,40% | Azioni |
| Siren, L.L.C. | $67.055.203 | 9.846.579 | 3,13% | Azioni |
| Octagon Capital Advisors LP | $66.010.992 | 9.693.244 | 3,08% | Azioni |
| GEODE CAPITAL MANAGEMENT, LLC | $44.685.322 | 6.560.394 | 2,08% | Azioni |
| Polar Capital Holdings Plc | $34.847.676 | 5.117.133 | 1,63% | Azioni |
| MPM BIOIMPACT LLC | $30.645.000 | 4.500.000 | 1,43% | Azioni |
| D. E. Shaw & Co., Inc. | $29.954.821 | 4.398.652 | 1,40% | Azioni |
| BAKER BROS. ADVISORS LP | $27.272.388 | 4.004.756 | 1,27% | Azioni |
| WELLINGTON MANAGEMENT GROUP LLP | $27.073.870 | 3.975.605 | 1,26% | Azioni |
| HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND | $26.460.262 | 3.885.501 | 1,23% | Azioni |
| GordonMD Global Investments LP | $24.501.508 | 723.185 | 1,14% | Azioni |
| Casdin Capital, LLC | $22.132.500 | 3.250.000 | 1,03% | Azioni |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $21.383.461 | 3.140.009 | 1,00% | Azioni |
| ADAR1 Capital Management, LLC | $20.705.573 | 3.040.466 | 0,97% | Azioni |
| Pictet Asset Management Holding SA | $18.868.474 | 2.770.701 | 0,88% | Azioni |
| Aberdeen Group plc | $15.847.905 | 2.327.152 | 0,74% | Azioni |
| FARALLON CAPITAL MANAGEMENT, L.L.C. | $15.322.500 | 2.250.000 | 0,71% | Azioni |
| NORGES BANK | $15.210.816 | 2.233.600 | 0,71% | Azioni |
| NORTHERN TRUST CORP | $15.160.491 | 2.226.210 | 0,71% | Azioni |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $14.986.733 | 2.200.695 | 0,70% | Azioni |
| MILLENNIUM MANAGEMENT LLC | $14.483.767 | 2.126.838 | 0,68% | Azioni |
| ORBIMED ADVISORS LLC | $13.620.000 | 2.000.000 | 0,64% | Azioni |
| RICE HALL JAMES & ASSOCIATES, LLC | $13.567.079 | 1.992.229 | 0,63% | Azioni |
| VANGUARD FIDUCIARY TRUST CO | $12.914.988 | 1.896.474 | 0,60% | Azioni |
| B Group, Inc. | $12.261.786 | 1.800.556 | 0,57% | Azioni |
| TYBOURNE CAPITAL MANAGEMENT (HK) LTD | $12.099.000 | 3.700.000 | 0,56% | Azioni |
| Affinity Asset Advisors, LLC | $11.917.500 | 1.750.000 | 0,56% | Azioni |
| BARCLAYS PLC | $11.104.787 | 1.630.659 | 0,52% | Azioni |
| CITADEL ADVISORS LLC | $10.455.305 | 1.535.287 | 0,49% | Azioni |
| HEIGHTS CAPITAL MANAGEMENT, INC | $10.215.000 | 1.500.000 | 0,48% | Azioni |
| Seven Fleet Capital Management LP | $9.940.323 | 1.504.400 | 0,46% | Azioni |
| Palo Alto Investors LP | $9.475.311 | 1.391.382 | 0,44% | Azioni |
| BANK OF AMERICA CORP /DE/ | $9.349.074 | 1.372.845 | 0,44% | Azioni |
| Granahan Investment Management, LLC | $8.888.255 | 1.305.177 | 0,41% | Azioni |
| Quantum Private Wealth, LLC | $5.529.903 | 812.027 | 0,26% | Azioni |
| FIRST TRUST ADVISORS LP | $5.387.860 | 791.169 | 0,25% | Azioni |
| JPMORGAN CHASE & CO | $5.157.078 | 766.282 | 0,24% | Azioni |
| Sands Capital Alternatives, LLC | $4.936.385 | 724.873 | 0,23% | Azioni |
| Bank of New York Mellon Corp | $4.753.180 | 697.971 | 0,22% | Azioni |
| BNP PARIBAS FINANCIAL MARKETS | $4.358.638 | 640.035 | 0,20% | Azioni |
Attivisti e proprietari del 5%+ 4 partecipazioni
Investitori che hanno depositato SEC Schedule 13D — proprietà effettiva superiore al 5% con l'intento di influenzare l'emittente (partecipazioni attiviste, campagne per il consiglio di amministrazione, M&A). Ogni riga mostra lo stato più recente noto della posizione di quel depositante.
| Depositante | Depositato | Partecipazione | Stato | Scopo | Deposito |
|---|---|---|---|---|---|
| Paul B Manning, The Paul B. Manning Revocable Trust dated May 10, 2000, The PBM 2023 Grantor Retained Annuity Trust, The PBM 2025 Grantor Retained Annuity Trust, BKB Growth Investments, LLC, BKB G2 Investments, LLC | 03 Giugno 2025 | 9,80% | Modifica | · | SEC |
| Paul B. Manning, The Paul B. Manning Revocable Trust dated May 10, 2000, The PBM 2023 Grantor Retained Annuity Trust, BKB Growth Investments, LLC, BKB G2 Investments, LLC ×3 depositi | 21 Agosto 2023 | · | Deposito iniziale | · | SEC |
| Astellas Pharma Inc., Astellas US Holding, Inc., Astellas Gene Therapies, Inc. (f/k/a Audentes Therapeutics, Inc.) ×2 depositi | 18 Agosto 2023 | · | Deposito iniziale | · | SEC |
| RA Session II, RA Session II, as Trustee of the Session 2020 Annuity Trust I, RA Session II, as Trustee of the Session 2020 Annuity Trust II | 05 Ottobre 2020 | · | Deposito iniziale | Investimento passivo | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Insider aziendali 11 insider · 4 dirigenti · 7 direttori
| Insider | Ruolo | Ultima attività | Azioni possedute | Acquisti 12m | Vendite 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Sean P. Nolan | Chief Executive Officer | 26 Gennaio 2026 S | 2.908.257 | 0 | 2 | $-840.196 |
| Kamran Alam | CHIEF FINANCIAL OFFICER | 04 Febbraio 2026 S | 1.442.131 | 0 | 3 | $-492.523 |
| Sukumar Nagendran | President and Head of R&D | 10 Aprile 2026 M | 1.136.410 | 0 | 6 | $-4.077.375 |
| Suyash Prasad | CMO and Head of R&D | 06 Luglio 2022 S | 530.589 | 0 | 0 | $0 |
| Alison S Long | Direttore | 02 Giugno 2025 A | 105.843 | 0 | 0 | $0 |
| Laura Sepp-Lorenzino | Direttore | 02 Giugno 2025 A | 105.843 | 0 | 0 | $0 |
| John A Stalfort III | Direttore | 02 Giugno 2025 A | 1.155.224 | 0 | 0 | $0 |
| Phillip B. Donenberg | Direttore | 02 Giugno 2025 A | 219.954 | 0 | 0 | $0 |
| Kathleen Reape | Direttore | 22 Giugno 2023 A | · | 0 | 0 | $0 |
| Paul B Manning | Proprietario del 10% | 30 Maggio 2025 P | 2.841.704 | 0 | 0 | $0 |
| R.A. Session II | Proprietario del 10% | 13 Luglio 2023 S | 8.871.747 | 0 | 0 | $0 |
Insider dai depositi SEC Modulo 3/4/5; netto = solo acquisti/vendite di mercato
Proprietà ETF Posseduti da 34 ETF
Il peso riflette solo le partecipazioni azionarie dirette (N-PORT); fondi a leva o basati su derivati possono detenere ulteriore esposizione swap non mostrata.
| Fondo | Peso | Unità | Aggiornato al | Fonte |
|---|---|---|---|---|
| IBRN · iShares Trust | 1,29% | 18.665 SH | 11 Settembre 2026 | Giornaliero |
| BBC · ETFis Series Trust I | 0,69% | 54.433 NS | 31 Luglio 2026 | N-PORT |
| FYC · First Trust Exchange-Traded AlphaDE… | 0,34% | 758.584 NS | 31 Luglio 2026 | N-PORT |
| LABU · Direxion Shares ETF Trust | 0,22% | 189.117 NS | 31 Luglio 2026 | N-PORT |
| ESSC · Strategy Shares | 0,15% | 9.374 NS | 31 Luglio 2026 | N-PORT |
| VFMO · VANGUARD WELLINGTON FUND | 0,11% | 332.492 SH | 19 Agosto 2026 | Giornaliero |
| FYX · First Trust Exchange-Traded AlphaDE… | 0,11% | 256.192 NS | 31 Luglio 2026 | N-PORT |
| IBBQ · Invesco Exchange-Traded Fund Trust … | 0,10% | 23.041 SH | 01 Ottobre 2026 | Giornaliero |
| IBB · iShares Trust | 0,10% | 2.030.172 SH | 11 Settembre 2026 | Giornaliero |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0,10% | 257.044 SH | 19 Agosto 2026 | Giornaliero |
| IWO · iShares Trust | 0,08% | 2.238.896 SH | 11 Settembre 2026 | Giornaliero |
| FAD · First Trust Exchange-Traded AlphaDE… | 0,07% | 68.720 NS | 31 Luglio 2026 | N-PORT |
| PWS · Pacer Funds Trust | 0,06% | 2.584 NS | 31 Luglio 2026 | N-PORT |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,05% | 1.379.816 SH | 19 Agosto 2026 | Giornaliero |
| RSSL · Global X Funds | 0,05% | 114.788 NS | 31 Luglio 2026 | N-PORT |
| IWM · iShares Trust | 0,04% | 6.131.004 SH | 11 Settembre 2026 | Giornaliero |
| ISCG · iShares Trust | 0,04% | 66.643 SH | 11 Settembre 2026 | Giornaliero |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0,02% | 117.429 SH | 01 Ottobre 2026 | Giornaliero |
| VXF · VANGUARD INDEX FUNDS | 0,02% | 3.043.718 SH | 19 Agosto 2026 | Giornaliero |
| VHT · VANGUARD WORLD FUND | 0,02% | 552.457 SH | 19 Agosto 2026 | Giornaliero |
| TEXN · iShares Trust | 0,02% | 680 SH | 11 Settembre 2026 | Giornaliero |
| FHLC · FIDELITY COVINGTON TRUST | 0,02% | 87.466 NS | 31 Luglio 2026 | N-PORT |
| WSML · iShares Trust | 0,01% | 8.303 SH | 11 Settembre 2026 | Giornaliero |
| DFAS · Dimensional ETF Trust | 0,00% | 78.390 NS | 31 Luglio 2026 | N-PORT |
| TILT · FlexShares Trust | 0,00% | 9.954 NS | 31 Luglio 2026 | N-PORT |
| ITOT · iShares Trust | 0,00% | 332.286 SH | 11 Settembre 2026 | Giornaliero |
| IWV · iShares Trust | 0,00% | 70.755 SH | 11 Settembre 2026 | Giornaliero |
| DCOR · Dimensional ETF Trust | 0,00% | 4.760 NS | 31 Luglio 2026 | N-PORT |
| DFUS · Dimensional ETF Trust | 0,00% | 5.870 NS | 31 Luglio 2026 | N-PORT |
| DFAU · Dimensional ETF Trust | 0,00% | 3.045 NS | 31 Luglio 2026 | N-PORT |
| DFAC · Dimensional ETF Trust | 0,00% | 10.179 NS | 31 Luglio 2026 | N-PORT |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 9.141.487 SH | 19 Agosto 2026 | Giornaliero |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 20.636 SH | 19 Agosto 2026 | Giornaliero |
| ISCB · iShares Trust | · | 9.303 SH | 11 Settembre 2026 | Giornaliero |
TSHA Consenso degli analisti Opinioni degli analisti, sia rialziste che ribassiste, target price a 12 mesi, potenziale di rialzo
rating · 18 analisti
COMPRA
Target mediano
$12.00
+159,2%
6 33,3%
Acquisto forte
11 61,1%
Compra
1 5,6%
Mantieni
0 0,0%
Vendi
0 0,0%
Vendita forte
Target Price a 12 Mesi
13 analisti · 2026-09-27Target medio $13.00 +180,8%
← Sotto tutti i target
Prezzo attuale $4.63
Basso$9.00
Media$13.00
Alto$19.00
Confronto Peer (GICS sub-settore industriale) Metriche chiave rispetto ai pari del settore
Base FY, prezzi alla chiusura dell'ultimo anno fiscale di ciascuna società.
| Ticker | Capitalizzazione di Mercato | P/E | Rev YoY | Margine Netto | ROE | Margine lordo |
|---|---|---|---|---|---|---|
| TSHA | $1.57B | -16.2 | 17.3% | -1115.3% | -44.0% | · |
| STOK | $1.87B | -264.5 | 404.5% | -3.7% | -2.0% | · |
| ZYME | $1.97B | -24.4 | 38.9% | -76.6% | -26.9% | · |
| XNCR | $1.10B | -12.3 | 13.7% | -73.2% | -14.0% | · |
| SNDX | $1.84B | -6.4 | 627.8% | -165.6% | -257.1% | · |
| RARE | $2.22B | -3.9 | 20.2% | -85.4% | -1613.2% | · |
| COAG | · | · | · | · | · | · |
| ANAB | · | -105.4 | 157.0% | · | · | · |
| INBX | $1.15B | -8.7 | 550.0% | -10773.5% | -365.9% | · |
| TYRA | $1.41B | -13.1 | · | · | -42.7% | · |
Ultime notizie Notizie recenti che menzionano questa società
Taysha Gene Therapies (TSHA) Rende Conto dei Risultati Finanziari per Q1 2026
Yahoo Finance · 4 mesi, 2 settimane fa
Canaccord Mantiene il Rating Buy su Taysha (TSHA) Dopo i Punti Salienti del Q1
Yahoo Finance · 4 mesi, 2 settimane fa
Taysha Gene Therapies (TSHA) Prezzo delle azioni in aumento del 343,45% rispetto ai livelli dell'anno scorso
Yahoo Finance · 5 mesi, 1 settimana fa
Le Mie Metriche La tua watchlist personale — righe selezionate da Fondamentali Completi
Scegli le metriche che contano per te: fai clic sul + accanto a qualsiasi riga in Fondamentali Completi sopra.
La tua selezione è salvata e ti segue su tutti i ticker.
Fonte: SEC 10-Q depositato Ago 11, 2026